Abstract
To the Editor We read with great interest the retrospective cohort study by Dr Bosch and colleagues1 comparing the effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock receiving vasopressor treatment. The authors found a 3.7% lower adjusted absolute risk difference of mortality or discharge to hospice in the hydrocortisone-fludrocortisone group and concluded that the addition of fludrocortisone was superior to hydrocortisone alone.